Pharmacy Department, Consorci Hospitalari de Vic, Vic, Barcelona, Spain.
Central Catalonia Chronicity Research Group (C3RG), University of Vic - Central University of Catalonia (UVIC-UCC), Vic, Barcelona, Spain.
Eur J Clin Pharmacol. 2022 Jan;78(1):127-137. doi: 10.1007/s00228-021-03207-9. Epub 2021 Aug 27.
This study aimed to assess the impact of the patient-centered prescription (PCP) model in medication adherence and effective prescribing in patients with multimorbidity.
Uncontrolled before-after study in an intermediate care facility in a mixed urban-rural district. Inpatients aged ≥ 65 years with multimorbidity exposed to polypharmacy before hospital admission were consecutively enrolled. Every patient's treatment plan was analyzed through the PCP model, which includes interventions aimed at improving medication adherence. The primary endpoint was the change in the proportion of adherent patients between pre-admission and after discharge for all regularly scheduled long-term medications, using the proportion of days covered (PDC). Secondary endpoints included the change on mean PDC for all long-term medications, number of long-term medications, proportion of patients with hyperpolypharmacy, medication regimen complexity index (MRCI) score, drug burden index (DBI) score, number of potential inappropriate prescribing (PIP), and proportion of patients with ≥ 2 PIPs.
Ninety-three non-institutionalized patients were included (mean age 83.0 ± SD 6.1 years). The proportion of adherent patients increased from 22.1 to 51.9% (P < 0.001). Intervention also improved mean PDC [mean difference (95% CI) 10.6 (7.7, 13.5)] and effective prescribing through a reduction on the number of long-term medications [- 1.3 (- 1.7, - 0.9)], proportion of patients exposed to hyperpolypharmacy (- 16.1%, P < 0.001), MRCI score [- 2.2 (- 3.4, - 1.0)], DBI score [- 0.16 (- 1.8, - 1.3)], number of PIPs [- 1.6 (- 1.8, - 1.3)], and proportion of patients with ≥ 2 PIPs (- 53.7%, P < 0.001).
Studied intervention provides significant effective prescribing and medication adherence enhancements in non-institutionalized older patients with multimorbidity and polypharmacy.
本研究旨在评估以患者为中心的处方(PCP)模式对患有多种疾病的患者药物依从性和有效处方的影响。
在一个城乡混合地区的中级护理机构进行的非对照前后研究。在住院前接受多药治疗的≥65 岁患有多种疾病的住院患者连续纳入研究。通过 PCP 模式分析每位患者的治疗计划,该模式包括旨在提高药物依从性的干预措施。主要终点是所有定期长期用药的服药依从患者比例在入院前和出院后的变化,采用覆盖天数比例(PDC)。次要终点包括所有长期用药的平均 PDC 变化、长期用药数量、超多重用药患者比例、药物治疗方案复杂性指数(MRCI)评分、药物负担指数(DBI)评分、潜在不适当用药(PIP)数量以及≥2 个 PIP 患者比例。
共纳入 93 例非住院患者(平均年龄 83.0±6.1 岁)。服药依从患者的比例从 22.1%增加到 51.9%(P<0.001)。干预还通过减少长期用药数量[平均差异(95%CI)10.6(7.7,13.5)]改善了平均 PDC,并通过降低超多重用药患者比例[−16.1%(P<0.001)]、MRCI 评分[−2.2(−3.4,−1.0)]、DBI 评分[−0.16(−1.8,−1.3)]、PIP 数量[−1.6(−1.8,−1.3)]和≥2 个 PIP 患者比例[−53.7%(P<0.001)]来改善有效处方。
研究干预为患有多种疾病和多重用药的非住院老年患者提供了显著的有效处方和药物依从性改善。